skip-to-main

SPIKEVAX 0.20 MG/ML DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)

Conditional Registration of SPIKEVAX 0.20 mg/mL dispersion for injection COVID-19 mRNA vaccine (nucleoside modified).

Summary of Product Characteristics

    ยฉ 2024 Moderna, Inc.

    MY-COV-2200001 09/2022